Cite
HARVARD Citation
Zangardi, M. et al. (2017). Ribociclib for post-menopausal women with HR+/HER2- advanced or metastatic breast cancer. Expert review of clinical pharmacology. 10 (11), pp. 1169-1176. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Zangardi, M. et al. (2017). Ribociclib for post-menopausal women with HR+/HER2- advanced or metastatic breast cancer. Expert review of clinical pharmacology. 10 (11), pp. 1169-1176. [Online].